MEET-UP Pharma: the 1st forum of the Healthcare Industry Professions in Auvergne.
Hypercholesterolemia: Valbiotis announces the major success of the Phase II HEART clinical study.
ON-LIGHT will take part on the 2nd Regional Research Days in the Hospital Centre, organized by Emile Roux Hospital Center of Puy-en-Velay on 23 and 24 June 2022.
Clermont Innovation Week Roundtable: How can and should health and climate-conscious agricultural approaches create value in our territories?
Le SMO Biopôle Clermont-Limagne publie son Panorama & chiffres Clés 2021.
Valbiotis announces approval to launch the two Phase II/III INSIGHT and INSIGHT 2 clinical studies, the last step in the development of TOTUM•854 for the reduction of blood pressure.
The EIB, with the support of the European Commission, is financing a €30 million loan for Carbios’ enzymatic recycling technology to support the Circular Economy.
STRAINCHEM enters the semi-industrial phase with France Relance.
Carbios receives support from the European Commission through the LIFE program.
Valbiotis: preclinical results for TOTUM•070 in hypercholesterolemia, selected and presented at the American Heart Association (AHA) annual meeting.